229 related articles for article (PubMed ID: 37537664)
1. Differential effects of SARS-CoV-2 variants on central nervous system cells and blood-brain barrier functions.
Proust A; Queval CJ; Harvey R; Adams L; Bennett M; Wilkinson RJ
J Neuroinflammation; 2023 Aug; 20(1):184. PubMed ID: 37537664
[TBL] [Abstract][Full Text] [Related]
2. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier.
Stüdle C; Nishihara H; Wischnewski S; Kulsvehagen L; Perriot S; Ishikawa H; Schroten H; Frank S; Deigendesch N; Du Pasquier R; Schirmer L; Pröbstel AK; Engelhardt B
Fluids Barriers CNS; 2023 Oct; 20(1):76. PubMed ID: 37875964
[TBL] [Abstract][Full Text] [Related]
4. Role of aging in Blood-Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19.
Adesse D; Gladulich L; Alvarez-Rosa L; Siqueira M; Marcos AC; Heider M; Motta CS; Torices S; Toborek M; Stipursky J
Fluids Barriers CNS; 2022 Aug; 19(1):63. PubMed ID: 35982454
[TBL] [Abstract][Full Text] [Related]
5. ACE-2, TMPRSS2, and Neuropilin-1 Receptor Expression on Human Brain Astrocytes and Pericytes and SARS-CoV-2 Infection Kinetics.
Malik JR; Acharya A; Avedissian SN; Byrareddy SN; Fletcher CV; Podany AT; Dyavar SR
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239978
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human plasma gelsolin reverses increased permeability of the blood-brain barrier induced by the spike protein of the SARS-CoV-2 virus.
Suprewicz Ł; Tran KA; Piktel E; Fiedoruk K; Janmey PA; Galie PA; Bucki R
J Neuroinflammation; 2022 Nov; 19(1):282. PubMed ID: 36434734
[TBL] [Abstract][Full Text] [Related]
7. The original strain of SARS-CoV-2, the Delta variant, and the Omicron variant infect microglia efficiently, in contrast to their inability to infect neurons: Analysis using 2D and 3D cultures.
Kase Y; Sonn I; Goto M; Murakami R; Sato T; Okano H
Exp Neurol; 2023 May; 363():114379. PubMed ID: 36914084
[TBL] [Abstract][Full Text] [Related]
8. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Paracellular Permeability in SARS-CoV-2 Blood-to-Brain Transcytosis.
Martinez TE; Mayilsamy K; Mohapatra SS; Mohapatra S
Viruses; 2024 May; 16(5):. PubMed ID: 38793666
[TBL] [Abstract][Full Text] [Related]
10. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
Murta V; Villarreal A; Ramos AJ
ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects.
Constant O; Barthelemy J; Bolloré K; Tuaillon E; Gosselet F; Chable-Bessia C; Merida P; Muriaux D; Van de Perre P; Salinas S; Simonin Y
Front Immunol; 2021; 12():697329. PubMed ID: 34386007
[TBL] [Abstract][Full Text] [Related]
12. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.
Alam SB; Willows S; Kulka M; Sandhu JK
Eur J Neurol; 2020 Nov; 27(11):2348-2360. PubMed ID: 32668062
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 causes dysfunction in human iPSC-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway.
Yamada S; Hashita T; Yanagida S; Sato H; Yasuhiko Y; Okabe K; Noda T; Nishida M; Matsunaga T; Kanda Y
Fluids Barriers CNS; 2024 Apr; 21(1):32. PubMed ID: 38584257
[TBL] [Abstract][Full Text] [Related]
14. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
[TBL] [Abstract][Full Text] [Related]
15. Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity?
Bauer L; van Riel D
mBio; 2023 Feb; 14(1):e0292022. PubMed ID: 36651750
[TBL] [Abstract][Full Text] [Related]
16. Proteomic landscape of astrocytes and pericytes infected with HIV/SARS-CoV-2 mono/co-infection, impacting on neurological complications.
Acharya A; Ambikan AT; Thurman M; Malik MR; Dyavar SR; Végvári Á; Neogi U; Byrareddy SN
Res Sq; 2023 Jun; ():. PubMed ID: 37398206
[TBL] [Abstract][Full Text] [Related]
17. The neurobiology of SARS-CoV-2 infection.
Meinhardt J; Streit S; Dittmayer C; Manitius RV; Radbruch H; Heppner FL
Nat Rev Neurosci; 2024 Jan; 25(1):30-42. PubMed ID: 38049610
[TBL] [Abstract][Full Text] [Related]
18. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.
Akkız H
Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924
[TBL] [Abstract][Full Text] [Related]
19. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
[TBL] [Abstract][Full Text] [Related]
20. Role of the SARS-CoV-2 Virus in Brain Cells.
Azargoonjahromi A
Viral Immunol; 2024 Mar; 37(2):61-78. PubMed ID: 38315740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
